China News Service, Hefei, October 23 (Zhang Qiang, Zhou Di, Chen Zhaolin) On October 23, organized by the Pharmaceutical Services Committee of the Chinese Pharmaceutical Association, the China-Japan Friendship Hospital and the First Affiliated Hospital of the University of Science and Technology of China (Anhui Provincial Hospital) ) Co-sponsored and co-authored by a number of medical institutions, the "Guidelines for the Quality Evaluation of Drug Catalogue Management in China's Medical Institutions" was officially released in Hefei, Anhui.

  This guide is mainly applicable to medical institutions at all levels in China that have the need for quality management of drug catalogs. The applicable population is management personnel of medical institutions at all levels, pharmacists, doctors, nursing staff and other relevant medical personnel.

  Liu Lihong, Chairman of the Pharmaceutical Services Professional Committee of the Chinese Pharmaceutical Association, Director of the Pharmacy Department and Chief Pharmacist of the China-Japan Friendship Hospital, introduced that China's medical institutions are widely distributed, and there is still a gap between their levels and service capabilities. This is based on the evaluation standards for drug catalogs that are generally applicable to medical institutions at all levels. Always vacant.

  Liu Lihong said that the Pharmaceutical Services Committee of the Chinese Pharmaceutical Association referred to the WHO guidelines and relevant policies and system documents of other countries and regions, combined with China’s national conditions and the actual conditions of medical institutions, and organized experts in related fields to formulate the "Guidelines for the Quality Evaluation of Drug Catalogue Management in Chinese Medical Institutions" 》, to carry out related work through the establishment of a guide working team and the establishment of a three-level indicator scoring system.

  Shen Aizong, member of the Pharmaceutical Services Professional Committee of the Chinese Pharmaceutical Association and deputy director of the Department of Pharmacy of the First Affiliated Hospital of the University of Science and Technology of China (Anhui Provincial Hospital), introduced that the guidelines are based on the best evidence available in relevant national laws, regulations and regulations, and aim to It is of great significance to provide a basis for the evaluation of the quality of drug catalogs in medical institutions in China, to promote the drug catalogs of medical institutions in China to meet the needs of rational drug use, to establish a quality evaluation mechanism for drug catalogs in medical institutions, and to promote the refined management of drug catalogs in medical institutions at all levels. An important innovative measure to serve the high-quality development of medical institutions in the professional field and serve the health of the people.

(over)